NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

Clinical Trial ID NCT01875601

PubWeight™ 12.62‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01875601

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 2010 6.34
2 Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer 2003 4.99
3 The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer. Front Immunol 2015 1.08
4 Targeting natural killer cells in cancer immunotherapy. Nat Immunol 2016 1.06
5 Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis. Cell Death Differ 2001 0.97
6 Trial watch: Immunostimulatory cytokines in cancer therapy. Oncoimmunology 2014 0.95
7 Common gamma chain cytokines in combinatorial immune strategies against cancer. Immunol Lett 2015 0.91
8 Molecular pathways: interleukin-15 signaling in health and in cancer. Clin Cancer Res 2014 0.90
9 Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12. Semin Oncol 2015 0.89
10 NK cell-based immunotherapies in Pediatric Oncology. J Pediatr Hematol Oncol 2015 0.85
11 Targeting CD8+ T-cell tolerance for cancer immunotherapy. Immunotherapy 2014 0.81
12 Immunotherapy of Childhood Sarcomas. Front Oncol 2015 0.81
13 New strategies in ewing sarcoma: lost in translation? Clin Cancer Res 2014 0.81
14 IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy. Cancer Res 2015 0.81
15 Immunotherapy in pediatric malignancies: current status and future perspectives. Future Oncol 2014 0.78
16 Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology 2015 0.77
17 Cellular immunotherapy for pediatric solid tumors. Cytotherapy 2014 0.77
18 Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy. J Immunol Res 2015 0.76
Next 100